New diabetes clinical trial: A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Published on: 2026-04-20T04:00:00Z
Conditions: Obesity & Overweight; Type 2 Diabetes
Interventions: Drug: DWRX5003; Drug: DWC202502; Drug: DWC202503; Other: DWRX5003P
Sponsors: Daewoong Pharmaceutical Co. LTD.
Not yet recruiting
https://ift.tt/PuaS4rE